Click here to close now.

SYS-CON MEDIA Authors: Liz McMillan, AppDynamics Blog, David Sprott, tru welu, Blue Box Blog

News Feed Item

Arterial Calcification Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Arterial Calcification Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

Arterial Calcification Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Calcification. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 5
Arterial Calcification 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Arterial Calcification Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Medestea Internazionale S.p.A. 27
Clinical Trial Overview of Medestea Internazionale S.p.A. 27
Amgen Inc. 28
Clinical Trial Overview of Amgen Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Medical University of Lodz 30
Clinical Trial Overview of Medical University of Lodz 30
Romanian Society of Nephrology 31
Clinical Trial Overview of Romanian Society of Nephrology 31
Okayama University 32
Clinical Trial Overview of Okayama University 32
Kingston General Hospital 33
Clinical Trial Overview of Kingston General Hospital 33
Osaka University 34
Clinical Trial Overview of Osaka University 34
Aarhus University 35
Clinical Trial Overview of Aarhus University 35
Mayo Clinic in Rochester 36
Clinical Trial Overview of Mayo Clinic in Rochester 36
National Taiwan University Hospital 37
Clinical Trial Overview of National Taiwan University Hospital 37
University of Kentucky 38
Clinical Trial Overview of University of Kentucky 38
Five Key Clinical Profiles 39
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Arterial Calcification Therapeutics, Global, Clinical Trials by Region, 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Arterial Calcification Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medestea Internazionale S.p.A., 2014* 27
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 28
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 29
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014* 30
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Romanian Society of Nephrology, 2014* 31
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2014* 32
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Kingston General Hospital, 2014* 33
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 34
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic in Rochester, 2014* 36
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 37
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 38

List of Figures

Arterial Calcification Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 67

To order this report: Arterial Calcification Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile ...
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will addresses this very serious issue o...
Cloud computing started a technology revolution; now DevOps is driving that revolution forward. By enabling new approaches to service delivery, cloud and DevOps together are delivering even greater speed, agility, and efficiency. No wonder leading innovators are adopting DevOps and cloud together! In his session at DevOps Summit, Andi Mann, Vice President of Strategic Solutions at CA Technologies, explored the synergies in these two approaches, with practical tips, techniques, research data, wa...
paradigm shifts in networking, to cloud and licensure, and all the Internet of Things in between. In 2014 automation was the name of the game. In his session at DevOps Summit, Matthew Joyce, a Sales Engineer at Big Switch, will discuss why in 2015 it’s complexity reduction. Matthew Joyce, a sales engineer at Big Switch, is helping push networking into the 21st century. He is also a hacker at NYC Resistor. Previously he worked at NASA Ames Research Center with the Nebula Project (where OpenSta...
SYS-CON Events announced today that SUSE, a pioneer in open source software, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place June 9-11, 2015, at the Javits Center in New York City, NY. SUSE provides reliable, interoperable Linux, cloud infrastructure and storage solutions that give enterprises greater control and flexibility. More than 20 years of engineering excellence, exceptional service and an unrivaled partner ecosystem power the products and support that help ...
SYS-CON Events announced today that MetraTech, now part of Ericsson, has been named “Silver Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. Ericsson is the driving force behind the Networked Society- a world leader in communications infrastructure, software and services. Some 40% of the world’s mobile traffic runs through networks Ericsson has supplied, serving more than 2.5 billion subscribers.
Enterprises are fast realizing the importance of integrating SaaS/Cloud applications, API and on-premises data and processes, to unleash hidden value. This webinar explores how managers can use a Microservice-centric approach to aggressively tackle the unexpected new integration challenges posed by proliferation of cloud, mobile, social and big data projects. Industry analyst and SOA expert Jason Bloomberg will strip away the hype from microservices, and clearly identify their advantages and d...
The multi-trillion economic opportunity around the "Internet of Things" (IoT) is emerging as the hottest topic for investors in 2015. As we connect the physical world with information technology, data from actions, processes and the environment can increase sales, improve efficiencies, automate daily activities and minimize risk. In his session at @ThingsExpo, Ed Maguire, Senior Analyst at CLSA Americas, will describe what is new and different about IoT, explore financial, technological and re...
"People are a lot more knowledgeable about APIs now. There are two types of people who work with APIs - IT people who want to use APIs for something internal and the product managers who want to do something outside APIs for people to connect to them," explained Roberto Medrano, Executive Vice President at SOA Software, in this SYS-CON.tv interview at Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that O'Reilly Media has been named “Media Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York City, NY. O'Reilly Media spreads the knowledge of innovators through its books, online services, magazines, and conferences. Since 1978, O'Reilly Media has been a chronicler and catalyst of cutting-edge development, homing in on the technology trends that really matter and spurring their adoption...
WebRTC defines no default signaling protocol, causing fragmentation between WebRTC silos. SIP and XMPP provide possibilities, but come with considerable complexity and are not designed for use in a web environment. In his session at @ThingsExpo, Matthew Hodgson, technical co-founder of the Matrix.org, discussed how Matrix is a new non-profit Open Source Project that defines both a new HTTP-based standard for VoIP & IM signaling and provides reference implementations.
There will be 150 billion connected devices by 2020. New digital businesses have already disrupted value chains across every industry. APIs are at the center of the digital business. You need to understand what assets you have that can be exposed digitally, what their digital value chain is, and how to create an effective business model around that value chain to compete in this economy. No enterprise can be complacent and not engage in the digital economy. Learn how to be the disruptor and not ...
2015 predictions circa 1970: houses anticipate our needs and adapt, city infrastructure is citizen and situation aware, office buildings identify and preprocess you. Today smart buildings have no such collective conscience, no shared set of fundamental services to identify, predict and synchronize around us. LiveSpace and M2Mi are changing that. LiveSpace Smart Environment devices deliver over the M2Mi IoT Platform real time presence, awareness and intent analytics as a service to local connecte...
The 5th International DevOps Summit, co-located with 17th International Cloud Expo – being held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the...
Thanks to widespread Internet adoption and more than 10 billion connected devices around the world, companies became more excited than ever about the Internet of Things in 2014. Add in the hype around Google Glass and the Nest Thermostat, and nearly every business, including those from traditionally low-tech industries, wanted in. But despite the buzz, some very real business questions emerged – mainly, not if a device can be connected, or even when, but why? Why does connecting to the cloud cre...